120 related articles for article (PubMed ID: 30108813)
1. Chiral disubstituted piperidinyl ureas: a class of dual diacylglycerol lipase-α and ABHD6 inhibitors.
Deng H; van der Wel T; van den Berg RJBHN; van den Nieuwendijk AMCH; Janssen FJ; Baggelaar MP; Overkleeft HS; van der Stelt M
Medchemcomm; 2017 May; 8(5):982-988. PubMed ID: 30108813
[TBL] [Abstract][Full Text] [Related]
2. Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of α/β-hydrolase domain containing 6 (ABHD6).
Hsu KL; Tsuboi K; Chang JW; Whitby LR; Speers AE; Pugh H; Cravatt BF
J Med Chem; 2013 Nov; 56(21):8270-9. PubMed ID: 24152295
[TBL] [Abstract][Full Text] [Related]
3. Identification of α,β-Hydrolase Domain Containing Protein 6 as a Diacylglycerol Lipase in Neuro-2a Cells.
van Esbroeck ACM; Kantae V; Di X; van der Wel T; den Dulk H; Stevens AF; Singh S; Bakker AT; Florea BI; Stella N; Overkleeft HS; Hankemeier T; van der Stelt M
Front Mol Neurosci; 2019; 12():286. PubMed ID: 31849602
[TBL] [Abstract][Full Text] [Related]
4. Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipase α and α/β-hydrolase domain 6.
Janssen FJ; Deng H; Baggelaar MP; Allarà M; van der Wel T; den Dulk H; Ligresti A; van Esbroeck AC; McGuire R; Di Marzo V; Overkleeft HS; van der Stelt M
J Med Chem; 2014 Aug; 57(15):6610-22. PubMed ID: 24988361
[TBL] [Abstract][Full Text] [Related]
5. Triazole Ureas Act as Diacylglycerol Lipase Inhibitors and Prevent Fasting-Induced Refeeding.
Deng H; Kooijman S; van den Nieuwendijk AM; Ogasawara D; van der Wel T; van Dalen F; Baggelaar MP; Janssen FJ; van den Berg RJ; den Dulk H; Cravatt BF; Overkleeft HS; Rensen PC; van der Stelt M
J Med Chem; 2017 Jan; 60(1):428-440. PubMed ID: 27992221
[TBL] [Abstract][Full Text] [Related]
6. α/β-Hydrolase domain-6 and saturated long chain monoacylglycerol regulate insulin secretion promoted by both fuel and non-fuel stimuli.
Zhao S; Poursharifi P; Mugabo Y; Levens EJ; Vivot K; Attane C; Iglesias J; Peyot ML; Joly E; Madiraju SR; Prentki M
Mol Metab; 2015 Dec; 4(12):940-50. PubMed ID: 26909310
[TBL] [Abstract][Full Text] [Related]
7. Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors.
Kaczor AA; Targowska-Duda KM; Patel JZ; Laitinen T; Parkkari T; Adams Y; Nevalainen TJ; Poso A
J Mol Model; 2015 Oct; 21(10):250. PubMed ID: 26350245
[TBL] [Abstract][Full Text] [Related]
8. Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors.
Patel JZ; Nevalainen TJ; Savinainen JR; Adams Y; Laitinen T; Runyon RS; Vaara M; Ahenkorah S; Kaczor AA; Navia-Paldanius D; Gynther M; Aaltonen N; Joharapurkar AA; Jain MR; Haka AS; Maxfield FR; Laitinen JT; Parkkari T
ChemMedChem; 2015 Feb; 10(2):253-65. PubMed ID: 25504894
[TBL] [Abstract][Full Text] [Related]
9. High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors.
Max D; Hesse M; Volkmer I; Staege MS
Cancer Sci; 2009 Dec; 100(12):2383-9. PubMed ID: 19793082
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Structure-Activity Relationships of α-Ketoheterocycles as sn-1-Diacylglycerol Lipase α Inhibitors.
Janssen FJ; Baggelaar MP; Hummel JJ; Overkleeft HS; Cravatt BF; Boger DL; van der Stelt M
J Med Chem; 2015 Dec; 58(24):9742-53. PubMed ID: 26584396
[TBL] [Abstract][Full Text] [Related]
11. The α/β-hydrolase domain 6 inhibitor WWL70 decreases endotoxin-induced lung inflammation in mice, potential contribution of 2-arachidonoylglycerol, and lysoglycerophospholipids.
Bottemanne P; Paquot A; Ameraoui H; Alhouayek M; Muccioli GG
FASEB J; 2019 Jun; 33(6):7635-7646. PubMed ID: 30896979
[TBL] [Abstract][Full Text] [Related]
12. α/β-Hydrolase domain-containing 6 (ABHD6) negatively regulates the surface delivery and synaptic function of AMPA receptors.
Wei M; Zhang J; Jia M; Yang C; Pan Y; Li S; Luo Y; Zheng J; Ji J; Chen J; Hu X; Xiong J; Shi Y; Zhang C
Proc Natl Acad Sci U S A; 2016 May; 113(19):E2695-704. PubMed ID: 27114538
[TBL] [Abstract][Full Text] [Related]
13. The Endocannabinoid System across Postnatal Development in Transmembrane Domain
Chesworth R; Long LE; Weickert CS; Karl T
Front Psychiatry; 2018; 9():11. PubMed ID: 29467679
[TBL] [Abstract][Full Text] [Related]
14. Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders.
Deng H; Li W
Acta Pharm Sin B; 2020 Apr; 10(4):582-602. PubMed ID: 32322464
[TBL] [Abstract][Full Text] [Related]
15. Monoacylglycerol signalling and ABHD6 in health and disease.
Poursharifi P; Madiraju SRM; Prentki M
Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():76-89. PubMed ID: 28880480
[TBL] [Abstract][Full Text] [Related]
16. Revisiting 1,3,4-Oxadiazol-2-ones: Utilization in the Development of ABHD6 Inhibitors.
Patel JZ; van Bruchem J; Laitinen T; Kaczor AA; Navia-Paldanius D; Parkkari T; Savinainen JR; Laitinen JT; Nevalainen TJ
Bioorg Med Chem; 2015 Oct; 23(19):6335-45. PubMed ID: 26344596
[TBL] [Abstract][Full Text] [Related]
17. Design and Synthesis of Quenched Activity-based Probes for Diacylglycerol Lipase and α,β-Hydrolase Domain Containing Protein 6.
van Rooden EJ; Kohsiek M; Kreekel R; van Esbroeck ACM; van den Nieuwendijk AMCH; Janssen APA; van den Berg RJBHN; Overkleeft HS; van der Stelt M
Chem Asian J; 2018 Nov; 13(22):3491-3500. PubMed ID: 29901868
[TBL] [Abstract][Full Text] [Related]
18. Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.
Manterola A; Bernal-Chico A; Cipriani R; Ruiz A; Pérez-Samartín A; Moreno-Rodríguez M; Hsu KL; Cravatt BF; Brown JM; Rodríguez-Puertas R; Matute C; Mato S
Neuropharmacology; 2018 Oct; 141():181-191. PubMed ID: 30171986
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
